The Effect of PC945 on Aspergillus or Candida Lung Infections in Patients With Asthma or Chronic Respiratory Diseases

Clinical trial NCT03745196 · TERMINATED

Trial details

NCT number: NCT03745196
Sponsor: Pulmocide Ltd
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Asthma Respiratory Candidiasis Respiratory Aspergillosis COPD Bronchiectasis

Start date: 2018-11-15
Primary completion: 2020-06-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.